1099 related articles for article (PubMed ID: 35304272)
1. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of Antrodia cinnamomea and Its Constituent Compound Dehydroeburicoic Acid 32 Against Alcoholic Fatty Liver Disease.
Xu L; Peng AK; Cao YN; Qiao X; Yue SS; Ye M; Qi R
Curr Mol Pharmacol; 2021; 14(5):871-882. PubMed ID: 33494689
[TBL] [Abstract][Full Text] [Related]
3. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
4. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
[TBL] [Abstract][Full Text] [Related]
5. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD
Xie L; Wen K; Li Q; Huang CC; Zhao JL; Zhao QH; Xiao YF; Guan XH; Qian YS; Gan L; Wang LF; Deng KY; Xin HB
Int J Biol Sci; 2021; 17(15):4305-4315. PubMed ID: 34803499
[TBL] [Abstract][Full Text] [Related]
6. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
Kim M; Yoo G; Randy A; Kim HS; Nho CW
Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
[TBL] [Abstract][Full Text] [Related]
7. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice.
Wang Q; Ou Y; Hu G; Wen C; Yue S; Chen C; Xu L; Xie J; Dai H; Xiao H; Zhang Y; Qi R
Br J Pharmacol; 2020 Apr; 177(8):1806-1821. PubMed ID: 31758699
[TBL] [Abstract][Full Text] [Related]
8. Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling.
Peng CH; Yang MY; Yang YS; Yu CC; Wang CJ
Am J Chin Med; 2017; 45(1):67-83. PubMed ID: 28161992
[TBL] [Abstract][Full Text] [Related]
9. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
10. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
11. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
12. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
13. Extract of Silphium perfoliatum L. improve lipid accumulation in NAFLD mice by regulating AMPK/FXR signaling pathway.
Xu J; Jia W; Zhang G; Liu L; Wang L; Wu D; Tao J; Yue H; Zhang D; Zhao X
J Ethnopharmacol; 2024 Jun; 327():118054. PubMed ID: 38484950
[TBL] [Abstract][Full Text] [Related]
14. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
15. Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis.
Peng A; Liu S; Fang L; Zhu Z; Zhou Y; Yue S; Ma Z; Liu X; Xue S; Qiu Y; Qi R
Eur J Pharmacol; 2022 Apr; 921():174841. PubMed ID: 35278405
[TBL] [Abstract][Full Text] [Related]
16. Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD.
Bórquez JC; Díaz-Castro F; La Fuente FP; Espinoza K; Figueroa AM; Martínez-Ruíz I; Hernández V; López-Soldado I; Ventura R; Domingo JC; Bosch M; Fajardo A; Sebastián D; Espinosa A; Pol A; Zorzano A; Cortés V; Hernández-Alvarez MI; Troncoso R
Metabolism; 2024 Mar; 152():155765. PubMed ID: 38142958
[TBL] [Abstract][Full Text] [Related]
17. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
18. Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice.
Zheng N; Wang H; Zhu W; Li Y; Li H
J Ethnopharmacol; 2024 Feb; 320():117401. PubMed ID: 37967775
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.
Wang X; Wang J; Ying C; Xing Y; Su X; Men K
BMC Pharmacol Toxicol; 2024 Jan; 25(1):7. PubMed ID: 38173037
[TBL] [Abstract][Full Text] [Related]
20. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
